AI in Medical Imaging Market Size, Diagnostic Imaging Innovations and Forecast

AI in Medical Imaging Market Overview Analysis By Fortune Business Insights

Market Snapshot

According to Fortune Business Insights: The global AI in medical imaging market was valued at USD 1.88 billion in 2025 and is projected to grow from USD 2.43 billion in 2026 to USD 29.95 billion by 2034, at a robust CAGR of 36.91% over the forecast period. North America held the dominant regional position, accounting for 40.42% of the global market share in 2025.

The market is experiencing significant growth driven by increasing volumes of diagnostic imaging and the operational efficiencies that AI integration brings to imaging workflows. AI in medical imaging encompasses a broad range of tools — from image reconstruction and anomaly detection to automated reporting and workflow triage — that reduce diagnostic bottlenecks and support clinical decision-making across radiology, oncology, cardiology, and pathology.

Get a Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/111496

Key Market Trends

A significant trend shaping the global market is the convergence of AI imaging solutions into multimodal, connected workflows. Hospitals are transitioning away from isolated, standalone AI tools toward integrated ecosystems where imaging AI, reporting, and documentation operate in unison. This shift reduces manual steps for radiologists — including triage, measurements, and reporting — while improving consistency and turnaround time across sites. In January 2026, Google released MedGemma 1.5, an updated healthcare-focused AI model that expanded support for CT scans, MRI, and histopathology and introduced MedASR, a medical speech-to-text system for clinical dictation — illustrating how technology leaders are embedding AI more deeply into end-to-end clinical workflows.

Market Dynamics

Drivers: Cloud adoption is a primary growth driver, accelerating access to AI-enabled imaging workflows across hospital networks. As healthcare providers migrate imaging data and radiology IT to the cloud, they gain the ability to deploy and update AI tools simultaneously across multiple sites, enable secure remote access for radiologists, and standardize protocols at scale. In February 2025, Philips expanded its cloud-based radiology informatics solutions to Europe, incorporating generative AI capabilities for enhanced radiology reporting — reflecting the broader shift toward cloud-native imaging infrastructure.

Restraints: The growing threat of cybersecurity incidents is the principal factor constraining market growth. As AI tools become more deeply integrated into PACS, RIS, and EHR systems, the exposure of sensitive patient data and clinical systems to cyberattacks increases. A March 2025 data security incident at SimonMed Imaging, which prompted the removal of all third-party vendor access to its systems, illustrates how breaches erode provider trust and slow AI procurement and deployment timelines.

Opportunities: Rapid technological advancement in AI imaging presents a major growth opportunity. Deep learning reconstruction, advanced image processing, and foundation model development are improving image quality, reducing scan noise, and enabling faster, lower-dose imaging without compromising diagnostic confidence. In May 2025, Sectra partnered with a U.S. health system to deploy its Sectra One Cloud enterprise imaging solution — including its AI Amplifier Service — across radiology, breast imaging, and cardiology departments, demonstrating how cloud-based AI platforms are being adopted at the enterprise level.

Challenges: Unclear reimbursement pathways and difficulty quantifying return on investment (ROI) pose a critical challenge to wider adoption. Most AI imaging tools are embedded within the radiologist's standard interpretation workflow and are not recognized as separately billable services by payers. A September 2025 study published in the Journal of the American College of Radiology found that nearly 53% of AI service claims submitted to Medicare between 2018 and 2023 were denied, representing USD 16.4 million in rejected payments. This reimbursement uncertainty leads procurement teams to delay approvals and keep AI pilots small, slowing enterprise-wide rollouts.

Segmentation Analysis

By Component: The software segment leads the market, as the primary value of AI in medical imaging is delivered through algorithm licenses, workflow orchestration tools, viewer integrations, and enterprise platforms. Buyers increasingly prefer subscription-based software models over managed services. The services segment, while smaller, is forecast to grow at a CAGR of 38.80%.

By Deployment: On-premise deployments dominate in 2025, as healthcare providers prioritize low-latency AI processing close to PACS and scanners, tighter data control, and resilience against internet outages. However, the cloud-based segment is the fastest-growing, projected to expand at a CAGR of 47.36%, as cloud infrastructure increasingly enables enterprise-wide AI deployment and scalability.

By Application: Radiology leads all application segments, serving as the primary gateway for medical image interpretation across emergency care, acute cases, and routine diagnostics. AI reduces manual steps in triage and reporting, improving throughput and prioritization. The pathology segment is projected to grow at the highest CAGR of 43.29%, reflecting rapid adoption of digital pathology and AI-assisted tissue analysis.

By Technology: Machine learning and deep learning dominate, underpinning the vast majority of imaging AI applications through their ability to detect complex patterns in image data and generate reliable diagnostic outputs. Natural language processing, which supports AI-assisted radiology reporting and clinical documentation, is projected to grow at a CAGR of 45.08% — the fastest among technology segments.

By Modality: CT scans lead by modality, driven by their high utilization in emergency and acute care settings and the large image volumes generated per study. Even incremental AI improvements in CT reconstruction and automation yield significant throughput gains. The MRI segment is expected to grow at a CAGR of 38.80%.

By End User: Hospitals and clinics dominate, interacting with the highest patient volumes and requiring standardized AI-enabled workflows across multiple departments and facilities. Diagnostic imaging centers are projected to grow at a CAGR of 40.54% as standalone imaging facilities increasingly invest in AI to remain competitive.

Connect with Our Expert for any Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/111496

Regional Outlook

North America is the largest market at USD 0.76 billion in 2025, driven by high imaging volumes, pressure to reduce report turnaround times, and significant cloud and AI infrastructure investment. The U.S. is estimated at approximately USD 0.90 billion in 2026. Europe, the second-largest region, is projected to reach USD 0.86 billion in 2026 at a growth rate of 36.25%, with Germany (USD 0.17 billion) and the U.K. (USD 0.10 billion) as key contributors, supported by government-backed digital health initiatives. Asia Pacific is the third-largest region, expected to reach USD 0.58 billion in 2026, led by China (USD 0.20 billion) and Japan (USD 0.14 billion), with growth driven by healthcare digitalization and imaging infrastructure expansion. Latin America and the Middle East & Africa are at earlier stages, with projected 2026 values of USD 0.13 billion and USD 0.01 billion (GCC), respectively.

Competitive Landscape

The global market has a consolidated structure, with Spectral AI, Viz.ai, Aidoc Medical, and Microsoft holding significant shares through strategic partnerships and continuous innovation. Other major players include GE HealthCare Technologies, Siemens Healthineers, Qure.ai, iCAD, RapidAI, HeartFlow, and Gleamer. Key recent developments include GE HealthCare's collaboration with Indonesia's SIHREN program to supply over 300 CT scanners (December 2025), Hyperfine receiving FDA clearance for its next-generation brain MRI system (June 2025), and GE HealthCare's acquisition of Intelligent Ultrasound's clinical AI software business for USD 51.0 million (July 2024).